- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Cancer researchers have long hypothesized that tumors release small amounts of proteins that could serve as earlier diagnostic indicators of cancer, but the search for such biomarkers has been hampered by the presence of large quantities of other proteins, such albumin, found in the blood and by the fact that these trace proteins are often unstable in blood. Now, an international research team from the United States and Italy has shown that it can use a new type of nanoparticle to selectively trap specific families of proteins from blood and protect them from degradation by enzymes in blood.
Lance Liotta of George Mason University and Caterina Longo from the University of Moderna and Regio Emilia led this investigation. The U.S. and Italian team published its findings in the journal Experimental Dermatology.
Previously, this research team had developed a set of highly porous nanoparticles whose interiors were decorated with different types of "bait" molecules that could selectively harvest large families of low-abundance proteins from blood. These nanoparticles were designed to exclude the relatively large protein-degrading enzymes prevalent in blood, and hence, could protect the trapped proteins from being broken down before they could be analyzed. In this set of experiments, the investigators used the particles to collect potential biomarkers for melanoma from the blood of human patients with this aggressive form of skin cancer. The researchers obtained blood from 29 patients with primary and metastatic melanoma as well as 26 patients with strange-looking moles that had not developed into melanomas.
The researchers found that levels of one particular protein, known as Bak, correlated highly with the development of moles into melanomas. These results were confirmed by histological examination of moles and melanoma tumors. The investigators note that although more patients need to be tested to confirm these results, it appears that serum Bak levels, measured after capture using these nanoparticles, could serve as a prognostic indicator for melanoma. The broader impact of this study lies with the demonstration that these baited nanoparticles can trap and protect rare proteins in human clinical blood samples and release those proteins for subsequent analysis for disease biomarkers.
This work, which was supported in part by the National Cancer Institute, is detailed in a paper titled, "A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum." An abstract of this paper is available through PubMed.
View abstract www.ncbi.nlm.nih.gov/pubmed/21158936
About NCI Alliance for Nanotechnology in Cancer
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.
The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.
Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.
For more information, please click here
Copyright © NCI Alliance for Nanotechnology in CancerIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Engineering the world’s smallest nanocrystal July 2nd, 2015
Newly-Developed Biosensor in Iran Detects Cocaine Addiction June 23rd, 2015